PKN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.766400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.535800E-01
Normal-vs-Stage2
9.591800E-01
Normal-vs-Stage3
3.180300E-02
Normal-vs-Stage4
3.697200E-01
Stage1-vs-Stage2
6.854200E-01
Stage1-vs-Stage3
1.379410E-01
Stage1-vs-Stage4
1.806620E-01
Stage2-vs-Stage3
1.101990E-01
Stage2-vs-Stage4
2.783800E-01
Stage3-vs-Stage4
3.083600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.596200E-01
Normal-vs-AfricanAmerican
9.964600E-01
Normal-vs-Asian
9.379800E-01
Caucasian-vs-AfricanAmerican
8.120000E-01
Caucasian-vs-Asian
9.079400E-01
AfricanAmerican-vs-Asian
9.260000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.585600E-01
Normal-vs-Female
9.084800E-01
Male-vs-Female
8.374400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.210400E-01
Normal-vs-Age(41-60Yrs)
7.070400E-01
Normal-vs-Age(61-80Yrs)
7.017600E-01
Normal-vs-Age(81-100Yrs)
2.571000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.531400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.373800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.399600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.635500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.230000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.167800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.895400E-01
Normal-vs-Daily Drinker
9.437000E-01
Normal-vs-Weekly Drinker
2.632400E-01
Normal-vs-Occasional Drinker
5.411800E-01
Normal-vs-Social Drinker
8.120000E-01
Non Drinker-vs-Daily Drinker
3.138600E-01
Non Drinker-vs-Weekly Drinker
5.382800E-01
Non Drinker-vs-Occasional Drinker
1.117700E-02
Non Drinker-vs-Social Drinker
3.526800E-01
Daily Drinker-vs-Weekly Drinker
2.168800E-01
Daily Drinker-vs-Occasional Drinker
1.989760E-01
Daily Drinker-vs-Social Drinker
8.800000E-01
Weekly Drinker-vs-Occasional Drinker
1.554460E-02
Weekly Drinker-vs-Social Drinker
1.482990E-01
Occasional Drinker-vs-Social Drinker
1.171750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.768200E-02
Normal-vs-Grade 2
1.843750E-02
Normal-vs-Grade 3
2.653800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.601800E-03
Grade 1-vs-Grade 3
3.675300E-03
Grade 1-vs-Grade 4
8.768200E-02
Grade 2-vs-Grade 3
2.907800E-01
Grade 2-vs-Grade 4
1.843750E-02
Grade 3-vs-Grade 4
2.653800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.450600E-01
Normal-vs-NonDiabetic
8.819400E-01
Diabetic-vs-NonDiabetic
1.150410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.145600E-01
Normal-vs-NoPancreatitis
7.706400E-01
Pancreatitis-vs-NoPancreatitis
7.402200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.641200E-01
Normal-vs-N1
9.214400E-01
N0-vs-N1
4.164200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.540400E-01
Normal-vs-TP53-NonMutant
7.892600E-01
TP53-Mutant-vs-TP53-NonMutant
4.993400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
